Skip to main content
logo
Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
2.240
0.00 (0.00%)
At close: Oct 2, 2026, 4:00 PM EDT
2.200
-0.040 (-1.79%)
After-hours: Oct 2, 2026, 7:30 PM EDT

Xenetic Biosciences Revenue

Xenetic Biosciences had revenue of $660.60K in the quarter ending June 30, 2026, with 11.99% growth. This brings the company's revenue in the last twelve months to $3.26M, up 33.30% year-over-year. In the year 2025, Xenetic Biosciences had annual revenue of $2.98M with 19.04% growth.

Revenue (ttm)
$3.26M
Revenue Growth
+33.30%
P/S Ratio
1.61
Revenue / Employee
$1,630,389
Employees
2
Market Cap
5.25M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20252.98M476.13K19.04%
Dec 31, 20242.50M-39.70K-1.56%
Dec 31, 20232.54M833.06K48.80%
Dec 31, 20221.71M546.23K47.06%
Dec 31, 20211.16M723.75K165.64%
Dec 31, 2020436.94K419.88K2,460.31%
Dec 31, 201917.07K--
Dec 31, 2018---
Dec 31, 20177.59M4.59M152.83%
Dec 31, 20163.00M--
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 20131.00M706.40K240.60%
Dec 31, 2012293.60K--
Aug 31, 2012---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
60 Degrees Pharmaceuticals1.21M
Lexaria Bioscience194.00K
AIM ImmunoTech95.00K
Cardio Diagnostics Holdings14.45K
Pulmatrix3.00K
Creative Medical Technology Holdings3.00K
Ernexa Therapeutics1.00K
Revenue Rankings

XBIO News

More News